These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37180414)

  • 21. Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.
    Staps P; van Gaalen J; van Domburg P; Steijlen PM; Ferdinandusse S; den Heijer T; Seyger MMB; Theelen T; Willemsen MAAP
    JIMD Rep; 2020 May; 53(1):61-70. PubMed ID: 32395410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sjögren-Larsson syndrome: Pediatric case report].
    García-Ortiz L; Gómez-López R; Rivera-Pedroza CI; Santillán-Hernández Y; Chima-Galán MDC; Gutiérrez-Salinas J
    Arch Argent Pediatr; 2018 Dec; 116(6):e773-e777. PubMed ID: 30457735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fundus autofluorescence changes in two cases of Sjögren-Larsson syndrome.
    Mirshahi A; Piri N
    Int Ophthalmol; 2009 Dec; 29(6):541-5. PubMed ID: 18830564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
    Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
    Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sjogren-Larsson syndrome associated hypermelanosis.
    Xu YC; Hou JQ; Zhu WJ; Li P
    J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.
    Rizzo WB
    Expert Opin Orphan Drugs; 2016 Apr; 4(4):395-406. PubMed ID: 27547594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
    Willemsen MA; Cruysberg JR; Rotteveel JJ; Aandekerk AL; Van Domburg PH; Deutman AF
    Am J Ophthalmol; 2000 Dec; 130(6):782-9. PubMed ID: 11124298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of Sjögren-Larsson syndrome with a large deletion in the ALDH3A2 gene confirmed by single nucleotide polymorphism array analysis.
    Gaboon NE; Jelani M; Almramhi MM; Mohamoud HS; Al-Aama JY
    J Dermatol; 2015 Jul; 42(7):706-9. PubMed ID: 25855245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
    Didona B; Codispoti A; Bertini E; Rizzo WB; Carney G; Zambruno G; Dionisi-Vici C; Paradisi M; Pedicelli C; Melino G; Terrinoni A
    J Hum Genet; 2007; 52(10):865-870. PubMed ID: 17902024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sjogren-Larsson syndrome: A rare neurocutaneous disorder.
    Subramanian V; Hariharan P; Balaji J
    J Pediatr Neurosci; 2016; 11(1):68-70. PubMed ID: 27195039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Turkish family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
    Incecık F; Herguner OM; Rizzo WB; Altunbasak S
    Ann Indian Acad Neurol; 2013 Jul; 16(3):425-7. PubMed ID: 24101836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular features of Sjogren-Larsson syndrome.
    Aslam SA; Sheth HG
    Clin Exp Ophthalmol; 2007; 35(1):98-9. PubMed ID: 17300584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
    Sarret C; Rigal M; Vaurs-Barrière C; Dorboz I; Eymard-Pierre E; Combes P; Giraud G; Wanders RJ; Afenjar A; Francannet C; Boespflug-Tanguy O
    J Neurol Sci; 2012 Jan; 312(1-2):123-6. PubMed ID: 21872273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-Stage Sjögren-Larsson Syndrome Maculopathy Imaged With OCT Angiography.
    Kovach JL
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):e78-e82. PubMed ID: 30222823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.
    Staps P; Rizzo WB; Vaz FM; Bugiani M; Giera M; Heijs B; van Kampen AHC; Pras-Raves ML; Breur M; Groen A; Ferdinandusse S; van der Graaf M; Van Goethem G; Lammens M; Wevers RA; Willemsen MAAP
    J Inherit Metab Dis; 2020 Nov; 43(6):1265-1278. PubMed ID: 32557630
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.